Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Zatosetron maleate
Price:
Purity: 99.41%
Stocking Period: 10 Day
Contact: Yang

123482-23-5

123482-23-5 structure

123482-23-5 structure

Name: Zatosetron (maleate)
Chemical Name: 5-Chloro-2,2-dimethyl-N-[(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct -3-yl]-2,3-dihydro-1-benzofuran-7-carboxamide
CAS Number: 123482-23-5
Molecular Formula: C₂₃H₂₉ClN₂O₆
Molecular Weight: 464.94
Catalog: Signaling Pathways GPCR/G Protein 5-HT Receptor
Create Date: 2018-06-19 20:34:21
Modify Date: 2024-01-01 20:02:22
Zatosetron maleate is a potent and selective 5HT3 receptor antagonist.

Name	5-Chloro-2,2-dimethyl-N-[(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct -3-yl]-2,3-dihydro-1-benzofuran-7-carboxamide
Synonyms	Zatosetron (maleate)

Description	Zatosetron maleate is a potent and selective 5HT3 receptor antagonist.
Related Catalog	Signaling Pathways >> GPCR/G Protein >> 5-HT Receptor Signaling Pathways >> Neuronal Signaling >> 5-HT Receptor Research Areas >> Neurological Disease
Target	5HT3 receptor[1]
In Vivo	Acute administration of 0.1 (n=21) and 0.3 (n=5) mg/kg Zatosetron maleate (Zatosetron) in male rats, but not 0.01, 0.05, 1.0 or 10 mg/kg (n=5, 3, 6 and 4, respectively) Zatosetron maleate or saline (n=5), leads to a significant reduction in the number of spontaneously active A10 dopamine cells. The number of spontaneously active A10 dopamine cells is not significantly different from 30 to 60 min post i.p. Zatosetron maleate (0.1 mg/kg) administration, shows a significant decrease by 60 to 90 min (0.65±0.11, P=0.03, n=5), a larger decrease by 90 to120 min (0.53±0.08, P=0.004, n=5) and remains at this significantly decreased level from 2 to 3 h (0.50+0.05, P=0.0004, n=5). Single-unit recordings show that Zatosetron maleate inhibits the activity of A10 dopamine cells following i.v. administration (ED50=0.12 mg/kg, n=8). Chronic administration of 0.1 mg/kg (n=16) Zatosetron maleate, but not 0.01, 1.0 or 10 mg/kg (n=4, 8 and 7, respectively) Zatosetron maleate or saline (n=5), leads to a significant reduction in the number of spontaneously active A10 dopamine cells[2].
Animal Admin	Male rats are used and Zatosetron maleate (Zatosetron) is prepared as an aqueous solution. Acutely treated animals receive i.p. injections of Zatosetron maleate or saline 2 h before electrophysiological recordings; Chronically treated animals receive injections (i.p.) of Zatosetron maleate or saline once daily for 21 days, and receive their last injection 2 h before electrophysiological recordings. After completion of nine tracks, some animals are administered either apomorphine HCI (0.14 or 0.01 mg/kg i.v.) or haloperidol (0.1 mg/kg i.v.) and the number of dopamine cells is then counted in three additional tracks[2].
References	[1]. Robertson DW, et al. Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships. J Med Chem. 1992 Jan 24;35(2):310-9. [2]. Rasmussen K, et al. The 5-HT3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons. Eur J Pharmacol. 1991 Nov 19; 205 (1):113-6.

Boiling Point	435.1ºC at 760 mmHg
Molecular Formula	C₂₃H₂₉ClN₂O₆
Molecular Weight	464.94
Flash Point	216.9ºC
PSA	45.06000
LogP	3.92120
Vapour Pressure	8.99E-08mmHg at 25°C
Storage condition	2-8℃

CHEMICAL IDENTIFICATION

RTECS NUMBER :: DF6473550

CAS REGISTRY NUMBER :: 123482-23-5

LAST UPDATED :: 199510

DATA ITEMS CITED :: 2

MOLECULAR FORMULA :: C19-H25-Cl-N2-O2.C4-H4-O4

MOLECULAR WEIGHT :: 464.99

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 38220 mg/kg/1Y-I

TOXIC EFFECTS :: Kidney, Ureter, Bladder - changes in tubules (including acute renal failure, acute tubular necrosis) Nutritional and Gross Metabolic - weight loss or decreased weight gain Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases

REFERENCE :: FAATDF Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1981- Volume(issue)/page/year: 22,494,1994

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Primate - monkey

DOSE/DURATION :: 3650 mg/kg/1Y-I

TOXIC EFFECTS :: Cardiac - EKG changes not diagnostic of specified effects

REFERENCE :: DCTODJ Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- Volume(issue)/page/year: 18,61,1995